Literature DB >> 7389213

Detection of an inhibitor of cell division in cultures of tumour cells with immunosuppressive activity in vitro.

J Werkmeister, R Zbroja, W McCarthy, P Hersey.   

Abstract

A number of previous reports have described the presence of factors which inhibit the response of lymphoid cells to phytohaemagglutinin. The present study describes an inhibitor of cell division synthesized and released directly from cultured tumour cells which appears to have similar immunosuppressive effects in vitro. This factor(s) was detected in a wide variety of cultured tumour cells and some cultures of normal foetal tissue. It inhibited the mitogenic response of lymphocytes to PHA and also the spontaneous cell division of a variety of cultured cells including the cells producing the factor. Pulse cytophotometry showed that cells were inhibited in the G1 phase. Production of the factor increased with time and was related to the number of cells in culture. Its synthesis was inhibited by cycloheximide. DNA and RNA synthesis was not required for its production. The factor appeared to have a high degree of biological activity in terms of the number of cultured cells required for production and in regard to the number of cells inhibited. The biological significance of this factor in vivo is unknown but in vitro it was shown to inhibit immunoglobulin and mitogen-induced responses which suggests it may play an important role in suppression of the immune response against tumour cells in the host.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7389213      PMCID: PMC1536937     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  Association of anergy with an immunosuppressive peptide fraction in the serum of patients with cancer.

Authors:  A H Glasgow; R B Nimberg; J O Menzoian; I Saporoschetz; S R Cooperband; K Schmid; J A Mannick
Journal:  N Engl J Med       Date:  1974-12-12       Impact factor: 91.245

2.  Lymphocyte blastogenic responses to cultured allogeneic tumor cells in vitro.

Authors:  R J Anderson; C M McBride; E M Hersh
Journal:  Cancer Res       Date:  1972-05       Impact factor: 12.701

3.  The effect of immunoregulatory globulin (IRA) upon lymphocytes in vitro.

Authors:  S R Cooperband; A M Badger; R C Davis; K Schmid; J A Mannick
Journal:  J Immunol       Date:  1972-07       Impact factor: 5.422

4.  The effect of immunoregulatory alpha globulin (IRA) on antigen-mediated macrophage immobilization in vitro.

Authors:  R C Davis; S R Cooperband; J A Mannick
Journal:  J Immunol       Date:  1971-03       Impact factor: 5.422

5.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

6.  Specific inhibition of lymphocyte blastogenic responses to mitogens by a factor produced by cultured human malignant lymphoma cells.

Authors:  E M Hersh; B Drewinko
Journal:  Cancer Res       Date:  1974-01       Impact factor: 12.701

7.  Inhibition of phytohemagglutinin-induced in vitro lymphocyte transformation by serum from patients with carcinoma.

Authors:  W F Sample; H R Gertner; P B Chretien
Journal:  J Natl Cancer Inst       Date:  1971-06       Impact factor: 13.506

Review 8.  Mitotic and functional homeostasis: a speculative review.

Authors:  W S Bullough
Journal:  Cancer Res       Date:  1965-11       Impact factor: 12.701

9.  Cancer camouflage.

Authors:  R Graham; J Graham
Journal:  Surg Gynecol Obstet       Date:  1969-04

10.  Antiinflammatory effects of murine malignant cells.

Authors:  R M Fauve; B Hevin; H Jacob; J A Gaillard; F Jacob
Journal:  Proc Natl Acad Sci U S A       Date:  1974-10       Impact factor: 11.205

View more
  11 in total

1.  Purification and some properties of proliferation suppressing factor from human lung adenocarcinoma PC-8.

Authors:  H Shinmoto; S Dosako; K Yamada; S Shirahata; H Murakami
Journal:  Cytotechnology       Date:  1990-09       Impact factor: 2.058

2.  Comparison of transforming growth factor beta and a human tumour-derived suppressor factor.

Authors:  S S Somers; J F Dye; P J Guillou
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

3.  Inhibition of lymphokine-activated killer cell generation by cultured tumor cell lines in vitro.

Authors:  P J Guillou; P C Sedman; C W Ramsden
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

4.  Supernatant derived from a human hepatocellular carcinoma cell line (PLC/PRF/5) activates a population of T-suppressor cells.

Authors:  A Keong; A R Rabson
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

5.  Characterization of an inhibitor of cell division released in tumour cell cultures.

Authors:  J Werkmeister; J Zaunders; W McCarthy; P Hersey
Journal:  Clin Exp Immunol       Date:  1980-09       Impact factor: 4.330

6.  Inhibitors of lymphocyte activation secreted by human melanoma cell lines.

Authors:  D Giacomoni; S Ben-Efraim; F Najmabadi; S Dray
Journal:  Med Oncol Tumor Pharmacother       Date:  1990

7.  Biologic characteristics of an immunosuppressive factor derived from a human lung cancer cell line.

Authors:  R D Wang; Z C Chen; Y Luo; Z H Feng
Journal:  J Tongji Med Univ       Date:  1989

8.  Immunoglobulin production stimulating and inhibiting factors derived from human lung adenocarcinoma PC-8 cells : Ig production stimulating factor in PC-8 cells.

Authors:  H Shinmoto; H Murakami; K Yamada; S Dosako; H Omura
Journal:  Cytotechnology       Date:  1988-11       Impact factor: 2.058

9.  Opposing changes in electrokinetic potential of spleen cells induced by factors from different tumour supernatants.

Authors:  D Vaillier; J Vaillier
Journal:  Immunology       Date:  1981-09       Impact factor: 7.397

10.  Identification and characterization of a tumor-derived immunosuppressive glycoprotein from murine melanoma K-1735.

Authors:  J B Putnam; J A Roth
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.